Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × avelumab × Lymphoid × Clear all

Phase

Phase 2 4 Phase 1 3 Phase EARLY_PHASE1 1 Phase 3 1 Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Lymphoid 1 Head & Neck 1 Genitourinary 1 Gastrointestinal 1 Dermatologic 1

Conditions

Lymphoma, B-Cell 1

Interventions

Cyclophosphamide 16 fludarabine 9 Rituximab 8 Vincristine 6 pembrolizumab 4 Radiotherapy 4 Immunotherapy, Adoptive 4 Granulocyte Colony-Stimulating Factor 4 Filgrastim 4 Etoposide 4 Doxorubicin 4 venetoclax 3 Prednisone 3 Nivolumab 3 Methotrexate 3 Magnetic Resonance Spectroscopy 3 Dexamethasone 3 68Ga-pentixafor 3 ibrutinib 2 Transplantation 2 Radiation 2 Phototherapy 2 Melphalan 2 Immunohistochemistry 2 Imiquimod 2 Ifosfamide 2 Exercise 2 Decitabine 2 Cord Blood Stem Cell Transplantation 2 Cholestanetriol 26-Monooxygenase 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03244176 2024-07-30

AvR-CHOP

Austin Health

Phase EARLY_PHASE1 Active not recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡